These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 1987451)

  • 1. Immunological evidence for N-acetyltransferase isozymes in the rabbit.
    Reeves PT; Kinnear BF; Minchin RF; Ilett KF
    Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic characterization of acetylator genotype-dependent and -independent N-acetyltransferase isozymes in homozygous rapid and slow acetylator inbred hamster liver cytosol.
    Trinidad A; Kirlin WG; Ogolla F; Andrews AF; Yerokun T; Ferguson RJ; Brady PK; Hein DW
    Drug Metab Dispos; 1989; 17(3):238-47. PubMed ID: 2568903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol.
    Yerokun T; Kirlin WG; Trinidad A; Ferguson RJ; Ogolla F; Andrews AF; Brady PK; Hein DW
    Drug Metab Dispos; 1989; 17(3):231-7. PubMed ID: 2568902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
    Martell KJ; Levy GN; Weber WW
    Mol Pharmacol; 1992 Aug; 42(2):265-72. PubMed ID: 1513324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
    Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
    Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
    Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
    Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.
    Kirlin WG; Trinidad A; Yerokun T; Ogolla F; Ferguson RJ; Andrews AF; Brady PK; Hein DW
    Cancer Res; 1989 May; 49(9):2448-54. PubMed ID: 2784998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
    Chung JG; Levy GN; Weber WW
    Drug Metab Dispos; 1993; 21(6):1057-63. PubMed ID: 7905384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase.
    Mattano SS; Land S; King CM; Weber WW
    Mol Pharmacol; 1989 May; 35(5):599-609. PubMed ID: 2725469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains.
    Hein DW; Smolen TN; Fox RR; Weber WW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):40-4. PubMed ID: 7120125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
    Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
    Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrahepatic expression of N-acetylator genotype in the inbred hamster.
    Hein DW; Kirlin WG; Ogolla F; Trinidad A
    Drug Metab Dispos; 1987; 15(1):68-73. PubMed ID: 2881761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylator genotype-dependent expression of arylamine N-acetyltransferase in human colon cytosol from non-cancer and colorectal cancer patients.
    Kirlin WG; Ogolla F; Andrews AF; Trinidad A; Ferguson RJ; Yerokun T; Mpezo M; Hein DW
    Cancer Res; 1991 Jan; 51(2):549-55. PubMed ID: 1985773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus.
    Hein DW; Rustan TD; Bucher KD; Miller LS
    J Pharmacol Exp Ther; 1991 Nov; 259(2):699-704. PubMed ID: 1941618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
    Andres HH; Weber WW
    Drug Metab Dispos; 1986; 14(4):382-5. PubMed ID: 2873982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver.
    Hein DW; Rustan TD; Bucher KD; Martin WJ; Furman EJ
    Drug Metab Dispos; 1991; 19(5):933-7. PubMed ID: 1686239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of acetyl coenzyme A:arylamine N-acetyltransferase from rapid and slow acetylator frog tissues.
    Ho CC; Lin TH; Lai YS; Chung JG; Levy GN; Weber WW
    Drug Metab Dispos; 1996 Feb; 24(2):137-41. PubMed ID: 8742223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
    Grant DM; Mörike K; Eichelbaum M; Meyer UA
    J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.